This is a non-core endpoint: only basic statistics are computed.

Petrositis

Endpoint Browser

H8_PETROS

No definition available.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H70.2 Cause of death: ICD-10 — H70.2 2 out of 7 registries used, show all original rules.	8
4. Check minimum number of events None	8
5. Include endpoints None	8
6. Filter based on genotype QC (FinnGen only)	7

Control definitions (FinnGen only)

Control exclude: H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H70
Name in latin: Petrositis

NAME	H8_PETROS
CONTROL_EXCLUDE	H8_MIDDLEMASTOID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H702
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H702
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Petrositis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	89	41	48
Only index persons	83	37	46
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	-	54.97	56.79
Only index persons	54.39	51.82	56.46

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7	-	-
Unadjusted period prevalence (%)	0.00	-	-
Median age at first event (years)	59.18	-	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044889) 12 lead EKG panel

+∞

1.43

6.9

4.8

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

+∞

1.02

14.9

21.1

13.93

13.92

—

(3037467) Urinalysis macro (dipstick) panel - Urine

+∞

0.74

2.7

4.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.48

0.0

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.00

0.47

0.0

2.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

0.47

0.0

4.4

—

29.29

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.00

0.23

0.0

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.23

0.0

1.8

—

(3019225) pH of Specimen

0.00

0.23

0.0

2.2

—

7.31

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

+∞

0.23

17.1

15.7

15.56

27.35

mg/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.23

0.0

1.9

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

+∞

0.23

17.3

16.8

71.57

73.26

ml/min/173m2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.00

0.23

0.0

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.00

0.23

0.0

4.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.00

0.23

0.0

4.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

+∞

0.23

21.6

19.3

4.04

4.03

mmol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

+∞

0.23

22.0

18.9

140.43

140.05

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.00

0.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.00

0.0

1.3

—

(40761511) CBC panel - Blood by Automated count

+∞

0.00

13.6

12.4

—

(3022145) Colonoscopy Study observation

0.00

0.0

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

+∞

-0.00

27.4

22.3

88.43

83.72

umol/l

—

(4024509) Urine culture

0.00

-0.00

0.0

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

38.80

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

+∞

-0.00

32.6

24.0

38.71

40.50

—

(3035941) MCH [Entitic mass]

+∞

-0.00

32.0

23.6

31.43

30.39

—

(3000963) Hemoglobin [Mass/volume] in Blood

+∞

-0.00

32.3

23.9

128.29

136.28

g/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007461) Platelets [#/volume] in Blood

+∞

-0.00

32.1

23.7

274.14

236.40

e9/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

+∞

-0.00

6.4

5.8

5.56

6.12

mmol/l

—

(3000330) Specific gravity of Urine by Test strip

0.00

-0.00

0.0

3.2

—

1.02

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

+∞

-0.00

32.1

23.7

95.43

91.45

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.00

-0.00

0.0

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PETROS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_PETROS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H8_PETROS – Petrositis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Petrositis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints